In the 1,25-(OH)2D3 treatment group, ICAT overexpression enhanced the stemness-inhibiting effect of 1,25-(OH)2D3 in AML cells, whereas ICAT knockout weakened this inhibitory effect. The gene discussed is CTNNBIP1; the disease is acute myeloid leukemia.